EN DE

Dr BILLA Oumar

Fiche personne

coordonnées

Unité de Recherche en Epidémiologie et Qualité de Vie
Centre Georges-François Leclerc
1 rue du Professeur Marion
BP 77980
21079 DIJON Cedex

03 45 34 80 67

obilla@cgfl.fr

Territoire

Bourgogne

affiliation

Centre Georges-François Leclerc (CGFL)

équipes/plateformes

Equipe Unité de recherche en Epidémiologie et Qualité de Vie

Recherche

Expertises :
- Biostatistiques

Publications

A Qualitative Study of the Experience of COVID-19 Patients in Burkina Faso.

Konaté B, Médah R, Traoré I, Ouedraogo S, Kaboré NF, Mamguem AK, Billa O, Kania D, Badolo H, Ouédraogo E, de Rekeneire N, Poda A, Diendéré AE, Ouédraogo B, Tinto H, Dabakuyo-Yonli TS

Am J Trop Med Hyg. 2023 12 18;:

The burden of the coronavirus disease 2019 virus infection in Burkina Faso: Results from a World Health Organization UNITY population-based, age-stratified sero-epidemiological investigation.

Ouedraogo S, Traoré IT, Kania D, Kaboré NF, Mamguem Kamga A, Badolo H, Yara M, Sanou G, Koné A, Kagoné ST, Ouédraogo E, Konaté B, Médah R, de Rekeneire N, Poda A, Diendere AE, Ouédraogo B, Billa O, Paradis G, Tinto H, Dabakuyo-Yonli TS

Influenza Other Respir Viruses. 2023 11;17(11):e13216

Incidence rate and predictors of COVID-19 in the two largest cities of Burkina Faso - prospective cohort study in 2021 (ANRS-COV13).

Kaboré NF, Ouédraogo S, Mamguem AK, Traoré IT, Kania D, Badolo H, Sanou G, Koné A, Yara M, Kagoné T, Ouédraogo E, Konaté B, Médah R, de Rekeneire N, Poda A, Diendéré AE, Ouédraogo B, Billa O, Paradis G, Dabakuyo-Yonli TS, Tinto H

BMC Infect Dis. 2023 06 12;23(1):394

Predictive value of health-related quality of life on radiotherapy-related toxicities in patients with head and neck cancer.

Billa O, Bonnetain F, Chamois J, Ligey A, Ganansia V, Renard S, Maillard S, Quivrin M, Vulquin N, Truntzer P, Noel G, Maingon P, Dabakuyo-Yonli TS

Support Care Cancer. 2023 04 14;31(5):268

Quality of life and perceived burden of the primary caregiver of patients aged 70 and over with cancer 5 years after initial treatment.

Barben J, Billa O, Collot J, Collot T, Manckoundia P, Bengrine-Lefevre L, Dabakuyo-Yonli TS, Quipourt V

Support Care Cancer. 2023 02 2;31(2):147

HER2-positive invasive lobular carcinoma: a rare breast cancer which may not necessarily require anti-HER2 therapy. A population-based study.

Kada Mohammed S, Billa O, Ladoire S, Jankowski C, Desmoulins I, Poillot ML, Coutant C, Beltjens F, Dabakuyo S, Arnould L

Breast Cancer. 2023 01 30;:

Does baseline quality of life predict the occurrence of complications in resectable esophageal cancer?

Sheng WG, Assogba E, Billa O, Meunier B, Gagnière J, Collet D, D'Journo XB, Brigand C, Piessen G, Dabakuyo-Yonli TS

Surg Oncol. 2021 Dec 30;40:101707

COVID-19 epidemiological, sociological and anthropological investigation: study protocol for a multidisciplinary mixed methods research in Burkina Faso.

Traoré IT, Ouedraogo S, Kania D, Kaboré FN, Konaté B, Médah R, Badolo H, de Rekeneire N, Kamga AM, Poda A, Diendere AE, Ouédraogo B, Ouédraogo E, Billa O, Tinto H, Dabakuyo-Yonli TS

BMC Infect Dis. 2021 Sep 3;21(1):896

Randomized Trial Assessing the Impact of Routine Assessment of Health-Related Quality of Life in Patients with Head and Neck Cancer.

Billa O, Bonnetain F, Chamois J, Ligey A, Ganansia V, Noel G, Renard S, Maillard S, Quivrin M, Vulquin N, Truntzer P, Dabakuyo-Yonli TS, Maingon P

Cancers (Basel). 2021 Jul 29;13(15):

Trends in endocrine therapy prescription and survival in patients with non-metastatic hormone receptor positive breast cancer treated with endocrine therapy: A population based-study.

Mamguem Kamga A, Billa O, Ladoire S, Poillot ML, Jolimoy G, Roignot P, Coutant C, Desmoulins I, Maynadie M, Dabakuyo-Yonli TS

Breast. 2021 Jun 11;59:79-86

Survival in patients with HR+/HER2- metastatic breast cancer treated with initial endocrine therapy versus initial chemotherapy. A French population-based study.

Simon J, Chaix M, Billa O, Kamga AM, Roignot P, Ladoire S, Coutant C, Arveux P, Quantin C, Dabakuyo-Yonli TS

Br. J. Cancer. 2020 Jul 17;:

Socio-economic and occupational outcomes of long-term survivors of gynaecological cancer: A French population-based study.

Mamguem Kamga A, Dumas A, Joly F, Simon J, Billa O, Poillot ML, Jolimoy G, Roignot P, Coutant C, Arveux P, Dabakuyo-Yonli TS

Eur J Cancer Care (Engl). 2020 Mar 25;:e13235

Long-Term Gynecological Cancer Survivors in Côte d'Or: Health-Related Quality of Life and Living Conditions.

Mamguem Kamga A, Dumas A, Joly F, Billa O, Simon J, Poillot ML, Darut-Jouve A, Coutant C, Fumoleau P, Arveux P, Dabakuyo-Yonli TS

Oncologist. 2018 Dec 21;:

Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort.

Billa O, Chalouni M, Salmon D, Poizot-Martin I, Gilbert C, Katlama C, Neau D, Chas J, Morlat P, Lacombe K, Naqvi A, Barange K, Gervais A, Bouchaud O, Rosenthal E, Lascoux-Combe C, Garipuy D, Alric L, Dominguez S, Vittecoq D, Goujard C, Duvivier C, Aumaitre H, Miailhes P, Zucman D, Simon A, Lazaro E, Raffi F, Esterle L, Wittkop L, Bani-Sadr F,

PLoS ONE. 2018 ;13(12):e0208657